188 related articles for article (PubMed ID: 1407458)
1. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
Couldwell WT; Antel JP; Yong VW
Neurosurgery; 1992 Oct; 31(4):717-24; discussion 724. PubMed ID: 1407458
[TBL] [Abstract][Full Text] [Related]
2. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
Couldwell WT; Uhm JH; Antel JP; Yong VW
Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway.
Baltuch GH; Yong VW
Brain Res; 1996 Feb; 710(1-2):143-9. PubMed ID: 8963653
[TBL] [Abstract][Full Text] [Related]
4. Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways.
Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
J Neurosurg; 1990 Jul; 73(1):98-105. PubMed ID: 2161913
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
Baltuch GH; Couldwell WT; Villemure JG; Yong VW
Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system.
Couldwell WT; Antel JP; Apuzzo ML; Yong VW
J Neurosurg; 1990 Oct; 73(4):594-600. PubMed ID: 2398390
[TBL] [Abstract][Full Text] [Related]
7. Staurosporine differentially inhibits glioma versus non-glioma cell lines.
Baltuch GH; Dooley NP; Couldwell WT; Yong VW
J Neurooncol; 1993 May; 16(2):141-7. PubMed ID: 8289091
[TBL] [Abstract][Full Text] [Related]
8. The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.
Pollack IF; Kawecki S
J Neurooncol; 1997 Feb; 31(3):255-66. PubMed ID: 9049854
[TBL] [Abstract][Full Text] [Related]
9. Disparity in expression of protein kinase C alpha in human glioma versus glioma-derived primary cell lines: therapeutic implications.
Zellner A; Fetell MR; Bruce JN; De Vivo DC; O'Driscoll KR
Clin Cancer Res; 1998 Jul; 4(7):1797-802. PubMed ID: 9676858
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of human and mouse astrocytes in vitro: signalling through the protein kinase C pathway.
Yong VW
J Neurol Sci; 1992 Aug; 111(1):92-103. PubMed ID: 1403003
[TBL] [Abstract][Full Text] [Related]
11. Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors.
Todo T; Kondo T; Kirino T; Asai A; Adams EF; Nakamura S; Ikeda K; Kurokawa T
Neurosurgery; 1998 Aug; 43(2):337-46. PubMed ID: 9696088
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
Hrzenjak M; Shain SA
Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.
Baltuch GH; Dooley NP; Rostworowski KM; Villemure JG; Yong VW
J Neurooncol; 1995; 24(3):241-50. PubMed ID: 7595754
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization and inhibition of deoxyribonucleic acid repair in rat glioma cells by long-term treatment with 12-O-tetradecanoylphorbol 13-acetate.
Zhang W; Hara A; Sakai N; Andoh T; Yamada H; Nozawa Y
Neurosurgery; 1993 Mar; 32(3):432-7; discussion 437. PubMed ID: 8455768
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
Pollack IF; Kawecki S
Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C and growth regulation of pituitary adenomas.
Couldwell WT; Law RE; Hinton DR; Gopalakrishna R; Yong VW; Weiss MH
Acta Neurochir Suppl; 1996; 65():22-6. PubMed ID: 8738488
[TBL] [Abstract][Full Text] [Related]
17. Opposite effects of the overexpression of protein kinase C gamma and delta on the growth properties of human glioma cell line U251 MG.
Mishima K; Ohno S; Shitara N; Yamaoka K; Suzuki K
Biochem Biophys Res Commun; 1994 May; 201(1):363-72. PubMed ID: 8198596
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
Couldwell WT; Weiss MH; Law RE; Hinton DR
J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
[TBL] [Abstract][Full Text] [Related]
20. The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy.
Bredel M; Pollack IF
Acta Neurochir (Wien); 1997; 139(11):1000-13. PubMed ID: 9442212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
